diphenyleneiodonium has been researched along with Scleroderma, Systemic in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dosoki, H | 1 |
Stegemann, A | 1 |
Taha, M | 1 |
Schnittler, H | 1 |
Luger, TA | 1 |
Schröder, K | 1 |
Distler, JH | 1 |
Kerkhoff, C | 1 |
Böhm, M | 1 |
1 other study available for diphenyleneiodonium and Scleroderma, Systemic
Article | Year |
---|---|
Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
Topics: Actins; Adult; Animals; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Computer S | 2017 |